Subjects suspected to have PCa were also studied with PSMA PET/CT, emphasizing its ability to act as a gatekeeper to better define if a patient should undergo a deeper clinical assessment or could be sent to AS. This evidence concerns the gene FOLH1 and posterior cortical atrophy.